Welcome, Guest Login | Signup | Portfolio | Bookmark | Contact
Markets

Symbol Name
Click for Symbol Help




Moody's Reviewing Eli Lilly For Downgrade After Drug Rejection

Wall Street Journal - Oct 20, 2010

Moody's Investors Service put Eli Lilly & Co. (LLY) under review for downgrade, following the U.S. Food & Drug Administration's rejection Tuesday of a proposed long-acting version of diabetes drug Byetta.

The regulator's request for more data to examine the effect of high doses of the drug, called Bydureon, on heart rhythms, likely pushes potential approval to 2012. Its approval had been widely expected and would have helped Lilly and development partners Amylin Pharmaceuticals Inc. (AMLN) and Alkermes Inc. (ALKS) get through an upcoming wave of patent expirations for best-sellers.

Lilly faces "significant" patent expirations beginning next year with the antipsychotic Zyprexa, its biggest drug, Moody's said. The ratings company has the company at A1, its fourth-highest rating.

"The Bydureon delay follows several other setbacks for Lilly related to pipeline progress and patent challenges," Moody's Senior Vice President Michael Levesque said.

Read Full Article from Wall Street Journal

- Posted: 2010-10-20 22:12:57


 More Stock Investor Place Company News  
Alibaba's Jack Ma Is Moving On, With an IPO Looming
Pfizer’s Possible Unit Shuffle Triggers Breakup Concern
Lululemon Raises 4th-Quarter Guidance But Misses Expectations; Shares Down
Dell Shares Surge After Report of Possible Buyout
ARMZ Seeks Rest of Uranium One for $1.3 Billion; Won’t Raise Bid

 Stock Investor Place Company News Archive
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008















Featured Companies | My Place | News | Markets | Big Board | Blogs | Products & Services

Copyright 2019 Stock Investor Place Inc. All Rights Reserved.
Disclaimer - Terms of Use - Privacy Policy - Advertise